While nausea, vomiting, and diarrhea are the most commonly reported gastrointestinal adverse effects with GLP-1-based therapies (occurring in 15-40% of patients depending on the agent and dose), FDA prescribing information for several of these medications does list dyspepsia (indigestion) and, in some cases, gastroesophageal reflux disease (GERD) as reported adverse reactions
The scale and coordination suggest these operations function less as opportunistic cons and more as sophisticated, organized cyber crime enterprises
Rubin says one out of four patients he treats for diet drug related PPH are minimally, if at all, overweight
Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome
are inventors on a patent application covering GLP-1 analogues described here
Vitamin B12 injections can be an effective way to combat fatigue and boost energy levels while taking Semaglutide
